New AI-Based Image Analysis Platform Enables Physicians to Analyze CT and MRI Scans in Half the Time of Traditional Methods
|
By MedImaging International staff writers Posted on 21 Jan 2021 |

Illustration
The US Food and Drug Administration (FDA) has granted 510(k) clearance for a new image analysis platform that enables physicians to analyze CT and MRI scans in half the time of traditional methods.
The new image analysis platform named AI Mass has been launched by AI Metrics, LLC (Birmingham, AL, USA) which has successfully implemented augmented intelligence - the concept of using artificial intelligence (AI) to improve human performance. The AI Metrics platform utilizes AI-assisted workflows to improve accuracy and consistency, and dramatically reduce errors.
The first application on AI Mass assists radiologists with image analysis and reporting of advanced cancer over time. During clinical trials for novel therapeutics, a patient’s response to therapy is assessed over time using detailed criteria. Such criteria require highly-controlled tumor measurements and calculations of percent changes in tumor size. In clinical practice, assessments are more subjective and lack standardization due to time constraints placed upon physicians.
“Our goal was to design a simple, intuitive platform in which radiologists could assess medical images from patients with minimal errors and a high level of accuracy, consistency, and efficiency,” said Dr. Andrew Smith, CEO and Founder of AI Metrics. “To do this, we had to break free from outdated methods and create an entirely new image viewer that supports AI and best-practice workflows that generate crystal clear data and reports. We started with advanced cancer and lymphoma, and are now broadening our platform to include early-stage cancers.”
“We solved the efficiency and standardization with a combination of AI and guided workflows that capture the best aspects of clinical trials and bring them into clinical practice,” added Smith. “This advanced technology completely changes the standard of care - for radiologists, oncologists and patients. As a practicing radiologist and researcher, I’ve envisioned for some time being able to use a system like this, and I am excited to see years of design work finally materialize into an incredible product.”
Related Links:
AI Metrics, LLC
The new image analysis platform named AI Mass has been launched by AI Metrics, LLC (Birmingham, AL, USA) which has successfully implemented augmented intelligence - the concept of using artificial intelligence (AI) to improve human performance. The AI Metrics platform utilizes AI-assisted workflows to improve accuracy and consistency, and dramatically reduce errors.
The first application on AI Mass assists radiologists with image analysis and reporting of advanced cancer over time. During clinical trials for novel therapeutics, a patient’s response to therapy is assessed over time using detailed criteria. Such criteria require highly-controlled tumor measurements and calculations of percent changes in tumor size. In clinical practice, assessments are more subjective and lack standardization due to time constraints placed upon physicians.
“Our goal was to design a simple, intuitive platform in which radiologists could assess medical images from patients with minimal errors and a high level of accuracy, consistency, and efficiency,” said Dr. Andrew Smith, CEO and Founder of AI Metrics. “To do this, we had to break free from outdated methods and create an entirely new image viewer that supports AI and best-practice workflows that generate crystal clear data and reports. We started with advanced cancer and lymphoma, and are now broadening our platform to include early-stage cancers.”
“We solved the efficiency and standardization with a combination of AI and guided workflows that capture the best aspects of clinical trials and bring them into clinical practice,” added Smith. “This advanced technology completely changes the standard of care - for radiologists, oncologists and patients. As a practicing radiologist and researcher, I’ve envisioned for some time being able to use a system like this, and I am excited to see years of design work finally materialize into an incredible product.”
Related Links:
AI Metrics, LLC
Latest Industry News News
- GE HealthCare Showcases AI-Enabled Nuclear Medicine Portfolio at SNMMI 2026
- GE HealthCare Highlights AI-Supported Radiation Therapy Tools at ESTRO 2026
- Nuclear Medicine Set for Continued Growth Driven by Demand for Precision Diagnostics
- GE HealthCare and NVIDIA Collaboration to Reimagine Diagnostic Imaging
- Patient-Specific 3D-Printed Phantoms Transform CT Imaging
- Siemens and Sectra Collaborate on Enhancing Radiology Workflows
- Bracco Diagnostics and ColoWatch Partner to Expand Availability CRC Screening Tests Using Virtual Colonoscopy
- Mindray Partners with TeleRay to Streamline Ultrasound Delivery
- Philips and Medtronic Partner on Stroke Care
- Siemens and Medtronic Enter into Global Partnership for Advancing Spine Care Imaging Technologies
- RSNA 2024 Technical Exhibits to Showcase Latest Advances in Radiology
- Bracco Collaborates with Arrayus on Microbubble-Assisted Focused Ultrasound Therapy for Pancreatic Cancer
- Innovative Collaboration to Enhance Ischemic Stroke Detection and Elevate Standards in Diagnostic Imaging
- RSNA 2024 Registration Opens
- Microsoft collaborates with Leading Academic Medical Systems to Advance AI in Medical Imaging
- GE HealthCare Acquires Intelligent Ultrasound Group’s Clinical Artificial Intelligence Business
Channels
Radiography
view channel
AI Tool Predicts Five-Year Breast Cancer Risk from Mammograms
Breast cancer risk assessment during routine screening is difficult because many women who develop the disease have no known genetic mutations or family history. Static risk tools provide limited discrimination... Read more
AI Mammography Tools Detect Early Breast Cancer Signs Years Before Diagnosis
Breast cancer screening aims to detect tumors before symptoms develop, but subtle mammographic changes can appear years before diagnosis and may be missed during routine reads. Delayed detection can lead... Read moreMRI
view channel
Cardiac MRI Detects Hidden Heart Dysfunction After Heart Attack
Myocardial infarction often leaves patients with persistent ventricular dysfunction that can progress without obvious signs. Detecting early decline remains difficult because standard measures may miss... Read more
AI Tool Reveals Cortical Lesions on Standard MRI in Multiple Sclerosis
Multiple sclerosis (MS) causes immune-mediated damage in the brain that leads to disability and cognitive decline. Clinicians have long recognized that lesions in the brain’s gray matter, or cortex, are... Read moreUltrasound
view channel
Portable 3D Ultrasound System Enables Reproducible Breast Cancer Monitoring
Breast cancer can develop between annual mammograms, and these interval cancers account for 20% to 30% of cases and tend to be more aggressive. The challenge is pronounced in people with dense breast tissue.... Read more
AI Ultrasound Platform Receives CE Mark for Prenatal Screening
Prenatal ultrasound is central to fetal anomaly screening, yet it remains one of the most technically demanding examinations in routine care. Because both image acquisition and interpretation are highly... Read moreNuclear Medicine
view channel
Second PSMA PET Identifies Disease in More Than Half of Negative Cases
Biochemical recurrence of prostate cancer after prostatectomy or radiation can be difficult to localize when imaging is negative. Uncertain disease sites may delay salvage therapy and expose patients to... Read moreNew PET Tracer Detects DVT and Pulmonary Embolism in One Scan
Deep vein thrombosis is the formation of clots in deep leg veins that can migrate to the lungs as pulmonary embolism. Rapid confirmation across both regions often requires multiple tests and can delay treatment.... Read moreGeneral/Advanced Imaging
view channel
Virtual Staining Technique Creates Histology Images from CT Data
Pulmonary hypertension, a disorder marked by pathological remodeling of the pulmonary vessels, often requires detailed histologic assessment. Yet routine pathology remains anchored in labor‑intensive,... Read more
CT-Derived Biomarker Predicts Outcomes in Gastric Cancer
Gastric cancer, also known as stomach cancer, is the fifth most common malignancy worldwide and often shows heterogeneous outcomes even within the same stage. Prognostic estimates typically rely on tumor-centric... Read more
AI Tool Enhances Response Assessment and Survival Prediction in Pleural Mesothelioma
Pleural mesothelioma, a cancer that grows as a thin, irregular layer along the lung wall, is difficult to measure on imaging. Clinicians rely on diameter-based Response Evaluation Criteria in Solid Tumors... Read moreImaging IT
view channel
Ambient AI Reporting Platform Streamlines Radiology Reporting
Radiology departments face growing imaging volumes and staffing shortages, creating reporting bottlenecks and pressure to maintain turnaround times. Conventional dictation tools document findings after... Read more
Interactive AI Tool Supports Explainable Lung Nodule Assessment
Lung cancer is a leading cause of cancer mortality, and timely characterization of pulmonary nodules on chest computed tomography (CT) is essential for directing care. Interpreting nodule morphology demands... Read more







